LuLym-T (autologous activated lymphocytes) / Lujia Biomedical 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
LuLym-T (autologous activated lymphocytes) / Lujia Biomedical
NCT05304481: Efficacy and Safety of Activated T Lymphocytes (ATL) in Hepatocellular Carcinoma

Recruiting
2
95
RoW
ATL administration
Lukas Biomedical Inc., Virginia Contract Research Organization Co., Ltd.
Hepatocellular Carcinoma
12/26
06/27

Download Options